Weekly Paclitaxel as Third Line Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Belloni, P. [1 ]
Cozzi, C. [1 ]
Zannier, F. [1 ]
Corradini, G. [1 ]
Candido, P. [1 ]
Della Torre, S. [1 ]
Toniolo, D. [1 ]
Fariciotti, A. [1 ]
Vismara, A. [1 ]
Bollina, R. [1 ]
机构：
[1] Oncol & Hematol G Salvini Gen Hosp, Rho, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S538 / S538
页数：1
相关论文
共 50 条
  • [1] Efficacy and toxicity of weekly paclitaxel as second/third line chemotherapy for advanced non-small cell lung cancer (NSCLC)
    Caballero, C
    Camps, C
    Garde, J
    Juarez, A
    Blasco, A
    Berrocal, A
    Safont, M
    Bremnes, R
    Iranzo, V
    Sirera, R
    [J]. LUNG CANCER, 2005, 49 : S239 - S239
  • [2] Weekly paclitaxel as second/third line chemotherapy for advanced and metastatic non-small cell lung cancer.
    Camps, C
    Caballero, C
    Garde, J
    Juarez, A
    Blasco, A
    Berrocal, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 693S - 693S
  • [3] Weekly paclitaxel (P) in patients with advanced non-small cell lung cancer (NSCLC).
    Nakagawa, K
    Fukuoka, M
    Saijo, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 704S - 704S
  • [4] Second line chemotherapy with weekly paclitaxel in advanced non-small cell lung cancer.
    Leon, L
    Cueva, J
    Cudel, T
    Calvo, M
    Graña, B
    Padín, E
    Candamio, S
    Barón, F
    López, R
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 121 - 121
  • [5] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [6] A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)
    Giorgio, CG
    Pappalardo, A
    Russo, A
    Giuffrida, D
    Santini, D
    Petralia, G
    Castorina, S
    Nunzio, R
    Failla, G
    Bordonaro, R
    [J]. LUNG CANCER, 2006, 51 (03) : 357 - 362
  • [7] Third-line chemotherapy with gemcitabine or docetaxel in patients with advanced non-small cell lung cancer (NSCLC).
    Morgensztern, D
    Lim, WT
    Subramanian, J
    Viswanathan, A
    Govindan, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 694S - 694S
  • [8] Weekly nab -paclitaxel in combination with carboplatin as first-line therapy in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Socinski, Mark A.
    Langer, Corey J.
    Okamoto, Isamu
    Hon, Jeremy K.
    Hirsh, Vera
    Dakhil, Shaker R.
    Page, Ray D.
    Orsini, James M.
    Zhang, Hui
    Renschler, Markus F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Weekly nab®-Paclitaxel In Combination With Carboplatin As First-line Therapy In Elderly Patients (pts) With Advanced Non-small Cell Lung Cancer (nsclc)
    Socinski, M. A.
    Langer, C. J.
    Okamoto, I.
    Hon, J. K.
    Hirsh, V.
    Dakhil, S. R.
    Page, R. D.
    Orsini, J.
    Zhang, H.
    Renschler, M. F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S215 - S215
  • [10] Weekly paclitaxel in advanced non-small cell lung cancer
    Chang, AYC
    Rubins, J
    Asbury, R
    Boros, L
    Hui, LF
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (04) : 10 - 13
12345